Teva Pharmaceuticals USA recalls Methylphenidate hydrochloride Extended-Release ablets USP (CII), 27 mg, 100-count bottle, Rx only, Teva Pharmaceuticals
Recalled February 19, 2020 · FDA recall D-0837-2020 · Teva Pharmaceuticals USA
Hazard
CGMP deviations: Product bottle may be absent of desiccant. · FDA Class II
Units
17,436 bottles
Sold at
USA Nationwide
Description
CGMP deviations: Product bottle may be absent of desiccant.
Product
Methylphenidate hydrochloride Extended-Release ablets USP (CII), 27 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 62037-734-01
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →